Prevalence and Outcomes of p.Val142Ile TTR Amyloidosis Cardiomyopathy: A Systematic Review

P Chandrashekar, L Alhuneafat… - Circulation: Genomic …, 2021 - Am Heart Assoc
Background: The p. Val142Ile variant, predominantly found among people of African
descent, is the most common cause of variant transthyretin amyloidosis and carriers …

Deep phenotyping of p.(V142I)‐associated variant transthyretin amyloid cardiomyopathy: Distinct from wild‐type transthyretin amyloidosis?

Y Razvi, A Ioannou, RK Patel, L Chacko… - European Journal of …, 2024 - Wiley Online Library
Aims Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an increasingly recognized
cause of heart failure. A total of 3–4% of individuals of African descent carry a TTR gene …

Cardiovascular burden of the V142I transthyretin variant

S Selvaraj, B Claggett, SH Shah, RJ Mentz, MG Khouri… - JAMA, 2024 - jamanetwork.com
Importance Individual cohort studies concur that the amyloidogenic V142I variant of the
transthyretin (TTR) gene, present in 3% to 4% of US Black individuals, increases heart …

[HTML][HTML] Extending the reach of expert amyloidosis care: A feasibility study exploring the staged implementation of a UK amyloidosis network

CH Choy, RP Steeds, J Pinney, S Baig, L Turvey-Haigh… - Clinical Medicine, 2024 - Elsevier
There has been an exponential increase in the diagnosis of transthyretin amyloid
cardiomyopathy (ATTR-CA). In response, the Midlands Amyloidosis Service was launched …

Open Library of Bioscience

Y Razvi, A Ioannou, RK Patel, L Chacko, N Karia… - ngdc.cncb.ac.cn
AIMS: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an increasingly recognized
cause of heart failure. A total of 3-4% of individuals of African descent carry a TTR gene …